Medovox
Read the full articleYou might also wanna read
Abivax Aktie: 1.691 Prozent in zwölf Monaten
Fast jeder zweite Anteilsschein von Abivax befindet sich mittlerweile in den Depots institutioneller Investoren. Während der Kurs nach einer
Abivax’s $920M Wall Street Haul Follows Cancer Risk Resolution, Paving Way for US Launch
Abivax clears safety concerns in ulcerative colitis trial, secures record $920M US offering, sending shares to fresh highs and setting the s
Abivax cashes in on investor enthusiasm with €807m raise - European Biotechnology Magazine
Abivax has raised $920m (€807m) in gross proceeds through a US public offering, only days after new obefazimod data helped calm investor con
Abivax: Wall Street Catches Up to the Data
Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underw
Abivax Secures $920M for IBD Drug US Launch - allsci.com
Abivax closes $920M public offering to fund US commercialization of inflammatory bowel disease candidate. Extends cash runway through Q4 202
Spero Therapeutics Aktie: 85-Prozent-Potenzial bis 4 Dollar
Spero Therapeutics hat eigentlich Grund zum Feiern. Mitte Juni gab die US-Gesundheitsbehörde FDA grünes Licht für das neue Medikament Utebzi
Comments
Sign in to join the conversation.
No comments yet. Be the first.